Genetics of congenital hyperinsulinism

Endocrine Pathology

Volumn 15, Issue 3, 2004, Pages 233-239

  Fournet, Jean Christophe ^a   Junien, Claudine ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Beta cells; Congenital hyperinsulinism; Genetics

Indexed keywords

2 OXOGLUTARIC ACID; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINO ACID; CITRIC ACID; GLUCOKINASE; GLUTAMATE DEHYDROGENASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MITOCHONDRIAL ENZYME; N ACETYLGLUTAMIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SHORT CHAIN FATTY ACID;

ABCC8 GENE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE; GENE MUTATION; HUMAN; HYPERAMMONEMIA; HYPERINSULINISM; HYPOGLYCEMIA; INFANT; KCNJ11 GENE; MITOCHONDRION; PANCREAS ISLET BETA CELL; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; RNA SPLICING; SYNDROME DELINEATION;

ATP-BINDING CASSETTE TRANSPORTERS; BUTYRYL-COA DEHYDROGENASE; GLUCOKINASE; GLUTAMATE DEHYDROGENASE; HUMANS; INFANT; INFANT, NEWBORN; ISLETS OF LANGERHANS; MUTATION; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 12844269202     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:15:3:233     Document Type: Conference Paper

References (27)

1. de Lonlay P, Fournet JC, Touati G, et al. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 161:37-48, 2002.
2. Rahier J, Sempoux C, Fournet JC, et al. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology 32:15-19, 1998.
3. Dunne MJ, Cosgrove KE, Shepherd RM, Ammala C. Potassium channels, sulphonylurea receptors and control of insulin release. Trends Endocrinol Metab 10:146-152, 1999.
4. Thameem F, Farook VS, Yang X, et al. The transcribed endosulfine alpha gene is located within a type 2 diabetes-linked region on 1q: sequence and expression analysis in Pima Indians. Mol Genet Metab 81:16-21, 2004.
5. Wang H, Craig RL, Schay J, et al. Alpha-endosulfine, a positional and functional candidate gene for type 2 diabetes: molecular screening, association studies, and role in reduced insulin secretion. Mol Genet Metab; 81:9-15, 2004.
6. Stanley CA. Hyperinsulinism in infants and children. Pediatr Clin North Am 44:363-374, 1997.
7. Yap F, Hogler W, Vora A, Halliday R, Ambler G. Severe transient hyperinsulinaemic hypoglycaemia: two neonates without predisposing factors and a review of the literature. Eur J Pediatr 163:38-41, 2004.
8. Nestorowicz A, Glaser B, Wilson BA, et al. Genetic heterogeneity in familial hyperinsulinism. Hum Mol Genet 7:1119-1128, 1998.
9. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 82:F79-86, 2000.
10. Shepherd RM, Cosgrove KE, O'Brien RE, Barnes PD, Ammala C, Dunne MJ. Hyperinsulinism of infancy: towards an understanding of unregulated insulin release. European Network for Research into Hyperinsulinism in Infancy. Arch Dis Child Fetal Neonatal Ed 82:F87-97, 2000.
11. Nestorowicz A, Wilson BA, Schoor KP, et al. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 5:1813-1822, 1996.
12. Otonkoski T, Ammala C, Huopio H, et al. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes 48:408-415, 1999.
13. Darendeliler F, Fournet JC, Bas F, et al. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures. J Pediatr Endocrinol Metab 15:993-1000, 2002.
14. Huopio H, Reimann F, Ashfield R, et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest 106:897-906, 2000.
15. Thornton PS, MacMullen C, Ganguly A, et al. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Diabetes 52:2403-2410, 2003.
16. Dekel B, Lubin D, Modan-Moses D, Quint J, Glaser B, Meyerovitch J. Compound heterozygosity for the common sulfonylurea receptor mutations can cause mild diazoxide-sensitive hyperinsulinism. Clin Pediatr (Phila) 41:183-186, 2002.
17. Suchi M, MacMullen C, Thornton PS, Ganguly A, Stanley CA, Ruchelli ED. Histopathology of congenital hyperinsulinism: retrospective study with genotype correlations. Pediatr Dev Pathol 6:322-333, 2003.
18. Verkarre V, Fournet JC, de Lonlay P, et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 102:1286-1291, 1998.
19. de Lonlay P, Fournet JC, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 100:802-807, 1997.
20. Fournet JC, Mayaud C, de Lonlay P, et al. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 158:2177-2184, 2001.
21. Kassem SA, Ariel I, Thornton PS, et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763-2769, 2001.
22. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1325-1333, 2000.
23. Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338: 1352-1357, 1998.
24. Stanley CA. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol Genet Metab 81(Suppl):45-51, 2004.
25. Glaser B, Kesavan P, Heyman M, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338: 226-230, 1998.
26. Dullaart RP, Hoogenberg K, Rouwe CW, Stulp BK. Family with autosomal dominant hyperinsulinism associated with A456V mutation in the glucokinase gene. J Intern Med 255:143-145, 2004.
27. Molven A, Matre GE, Duran M, et al. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 53:221-227, 2004.